首页 › 基金 › DV EQUITIES, LLC › CTMX
DV EQUITIES, LLC 对 CTMX 的持仓历史
CYTOMX THERAPEUTICS INC. · 医疗保健
DV EQUITIES, LLC 在 Q3 2026 的 13F 申报中披露持有 CTMX(CYTOMX THERAPEUTICS INC.)714,000 股,市值约 US$1.9M,约占其申报组合的 0.38%,在其申报持仓中市值排名第 34 位。 DV EQUITIES, LLC 最近 2 个申报季度中有 2 个季度披露了 CTMX 持仓,最早可追溯至 Q2 2026。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
DV EQUITIES, LLC 对 CTMX 的持仓演变
DV EQUITIES, LLC 于 Q2 2026 首次披露 CTMX 持仓:714,000 股(约 US$2.7M)。 在 2 次申报中,DV EQUITIES, LLC 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 714,000 股、市值约 US$1.9M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2026 | 714.00K | $2.68M | 新进 |
| Q3 2026 | 714.00K | $1.94M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 CTMX 与 13F 数据
CTMX(CYTOMX THERAPEUTICS INC.)属于医疗保健行业。我们追踪的基金中还有 33 只申报持有 CTMX,申报仓位最大的包括:Kynam Capital Management, LP (US$57.5M), PERCEPTIVE ADVISORS LLC (US$25.2M), Elmind Capital, LP (US$12.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 CTMX 的基金
- Kynam Capital Management, LP 21.14M 股 · $57.50M · Q3 2026
- PERCEPTIVE ADVISORS LLC 9.27M 股 · $25.21M · Q3 2026
- Elmind Capital, LP 4.55M 股 · $12.38M · Q3 2026
- Nextech Invest Ltd. 4.45M 股 · $12.10M · Q3 2026
- Eversept Partners, LP 3.54M 股 · $9.64M · Q3 2026
- Seven Fleet Capital Management LP 1.09M 股 · $2.95M · Q3 2026
更多关于 DV EQUITIES, LLC
常见问题
How long has DV EQUITIES, LLC held CTMX?
DV EQUITIES, LLC has disclosed CTMX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is DV EQUITIES, LLC's current position in CTMX?
As of Q3 2026, DV EQUITIES, LLC holds 714.00K shares of CTMX (CYTOMX THERAPEUTICS INC.), valued at $1.94M, representing 0.38% of its reported portfolio and ranking #34.
Has DV EQUITIES, LLC been buying or selling CTMX?
In the latest 13F filing (Q3 2026), DV EQUITIES, LLC held unchanged its position in CTMX.
Which other funds hold CTMX?
Other major institutional holders of CTMX include Kynam Capital Management, LP, PERCEPTIVE ADVISORS LLC, Elmind Capital, LP, among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.